Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress

Pancreatic ductal adenocarcinoma (PanCa) is an extremely lethal disease characterized by mutations of p53 in up to 70% of cases. Our previous studies have confirmed that hyperglycemia may be the first clinical manifestation for the early diagnosis of PanCa. In this article, we showed that targeted k...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiao, He, Xiangyi, Ben, Qiwen, Wang, Weiyi, Song, Huan, Ye, Qiao, Zang, Yi, Li, Weiguang, Chen, Ping, Yao, Weiyan, Yuan, Yaozong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650341/
https://www.ncbi.nlm.nih.gov/pubmed/29088786
http://dx.doi.org/10.18632/oncotarget.19402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650341/
https://www.ncbi.nlm.nih.gov/pubmed/29088786
http://dx.doi.org/10.18632/oncotarget.19402

Ejemplares similares